AVM Biotechnology Founder and CSO to Present Company Information and Clinical Trial Progress at...
SEATTLE, April 19, 2022--(BUSINESS WIRE)--AVM Biotechnology, a clinical-stage company developing AVM0703, a small molecule that mobilizes endogenous gamma delta TCR+ and invariant TCR+ bispecific Natural Killer T-like cells, today announced that Founder and Chief...
Discovering a molecule that could interfere with SARS-CoV-2 replication
Interview conducted by Emily Henderson, B.Sc.Sep 22 2020
Thought LeadersStepan NersisyanResearcher in Biology and BiotechnologyHSE University
In this interview, News-Medical speaks to Stepan Nersisyan about his research efforts during the COVID-19 pandemic, and his discovery...
Groundbreaking trial aims for precise dietary data collection
Scientists are recruiting adults from across the UK to take part in a groundbreaking trial to accurately track what they eat and drink in their daily lives. The findings of their research could pave...
Schrödinger’s Equation: Physics + Machine Learning = Drug Discovery
In developing drugs using a platform that joins physics with machine learning, Schrödinger sees more than a passing resemblance to the studio whose Toy Story and other computer-generated movies changed the practice of animation.
Just...
Novavax Reports Varying Success vs. COVID-19 Variants
Novavax electrified investors last night by announcing that its COVID-19 vaccine NVX-CoV2373 showed efficacy of 89.3% in the company’s first analysis of data from a Phase III trial in the U.K., where a variant...
Seaport Eyes Platform, Pipeline Growth with $225M Series B
Daphne Zohar, founder and CEO of Seaport Therapeutics
Seaport Therapeutics said today it has closed on an oversubscribed $225 million Series B financing, with the proceeds set to be used toward enhancing its Glyph technology...
Cytiva Introduces FlexFactory to Poland
SyVento Biotech, a CDMO, opened its new mRNA manufacturing facility, a FlexFactory delivered by Cytiva, spanning over 7,000 m2, including lab and production areas, offices, and shared spaces. It establishes SyVento Biotech as a...
Protective Immune Cells’ Function Altered by Cigarette Smoke Components
Cigarette smoking is prevalent worldwide and causes numerous diseases, yet our understanding of how cigarette smoke (CS) causes serious respiratory illnesses is incomplete, and has held back the development of effective treatments. Researchers headed...
CDMO Roundup
According to the latest study from BCC Research, the demand for “Global Market Opportunities and Competitive Landscape for CDMOs” was valued at $128.0 billion in 2023 and is expected to grow from $136.6 billion...
Humanity’s quest to discover the origins of life in the universe
“We are living in an extraordinary moment in history,” says Didier Queloz, who directs ETH Zurich’s Centre for Origin and Prevalence of Life and the Leverhulme Centre for Life in the Universe at Cambridge....
